Gabapentin Tablet
FDA Label NDC 70771-1916

1 label section · Submitted to the FDA by Zydus Lifesciences Limited · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Gabapentin (NDC 70771-1916). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 70771-1861-9 in bottle of 90 tablets

Gabapentin tablets, 300 mg

Rx only

90 tablets

Gabapentin 300 mg (Ba40713a 2f22 4276 A664 355e7442cda4 01)

Gabapentin 300 mg (Ba40713a 2f22 4276 A664 355e7442cda4 01)

gabapentin 300 mg

NDC 70771-1862-9 in bottle of 90 tablets

Gabapentin tablets, 600 mg

Rx only

90 tablets

Gabapentin 600 mg (Ba40713a 2f22 4276 A664 355e7442cda4 02)

Gabapentin 600 mg (Ba40713a 2f22 4276 A664 355e7442cda4 02)

gabapentin 600 mg

NDC 70771-1916-6 in bottle of 60 tablets

Gabapentin tablets, 450 mg

Rx only

60 tablets

Gabapentin 450 mg (Ba40713a 2f22 4276 A664 355e7442cda4 03)

Gabapentin 450 mg (Ba40713a 2f22 4276 A664 355e7442cda4 03)

NDC 70771-1917-6 in bottle of 60 tablets

Gabapentin tablets, 750 mg

Rx only

60 tablets

Gabapentin 750 mg (Ba40713a 2f22 4276 A664 355e7442cda4 04)

Gabapentin 750 mg (Ba40713a 2f22 4276 A664 355e7442cda4 04)

NDC 70771-1918-6 in bottle of 60 tablets

Gabapentin tablets, 900 mg

Rx only

60 tablets

Gabapentin 900 mg (Ba40713a 2f22 4276 A664 355e7442cda4 05)

Gabapentin 900 mg (Ba40713a 2f22 4276 A664 355e7442cda4 05)

* Please review the disclaimer below.